Serve predicts the shift from humans to robots in the last-mile logistics industry will create a $450 billion opportunity by ...
S-606001 has the potential to become the first oral substrate reduction therapy for Pompe diseaseOSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer ...
BUTTERWORTH: Around 10 to 12 elderly folk living with dementia get a "sense of mission" every time they get to operate their pop-up cafe.
The liver of a 56-year-old male patient was severely damaged. Chronic hepatitis B, compounded by alcoholic liver injury, ...
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
S. Korea's healthcare system is becoming increasingly concentrated in Seoul, leaving many rural communities with limited ...
According to the market research study published by Vyansa Intelligence, the Global Diagnostic Labs Market is projected to grow at a CAGR ...
Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a non-invasive alternative to injections.
ADFEST 2026 tonight announced the winners from the second of its two Lotus Awards presentations, covering nine categories: ...
With disasters more intense and more frequent, there is less time to recover and mourn. See how new technology – and new approaches to the strain – aim to help.